CRLBF · Cresco Labs Inc.

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31 st , 2025 on Thursday, March 5, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. Event : Cresco Labs Fourth Quarter 2025 Earnings Conference Call Date : Thursday, March 5, 2026 Time : 8:30 am ET Webcast: LINK Conference Call Registration: LINK Dial-in : 1-833-470-1428 (US Toll Free), 1-646-844-6383 (US Local) Access Code : 152399 Archived access to the webcast will be available for one year on the Cresco Labs investor relations website. About Cresco Labs Inc. Cresco Labs’ mission is to normalize and professionalize the

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN OR INTO THE UNITED STATES Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“ Cresco Labs ” or the “ Company ”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it has entered into an equity distribution agreement (the “ Equity Distribution Agreement “) with Haywood Securities Inc. pursuant to which the Company may, from time to time, sell up to approximately US$100 million (C$140 million) of subordinate voting shares (“ Subordinate Voting Shares “) in the capital of the Company (the “ ATM Program ”). The Company intends to use the net proceeds of the ATM Program, if any, principally for general corporate purposes, including potential future acquisitions. “Establishing this ATM program provides us with another flexible tool to support our strategic objectives as the industry continues to mature and

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Tamarac, located at 6001 N University Drive in Tamarac, Fla. It is the Company’s 31 st dispensary in Florida and 72 nd nationwide. Cresco Labs opened a new Sunnyside dispensary at 6001 N University Drive in Tamarac, Florida. “Florida is the largest medical market in the country, and opening Sunnyside Tamarac reinforces our long-term commitment to serving patients across the state,” said Charlie Bachtell, CEO of Cresco Labs. “We’re focused on ensuring more patients can rely on Sunnyside for high-quality products and an approachable, educational retail experience.” Sunnyside Tamarac offers a wide selection of cannabis products from Cresco Labs’s industry-leading brand portfolio, including Cresco, FloraCal, Supply, Good News, Remedi and Sunnyside. The store also has a curated selection of accessories. Patients can place orders in store or online at